DEBRIDAT, granules for oral suspension in a vial bottle, 152.5 g
Active ingredients: Trimebutine
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspensionbottle, 152.5 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEBRIDAT, granulés pour suspension buvable en flacon
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 152,5 g avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67705779CIP73028252CIP133400930282526Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRIMÉBUTINEgranulés | 0,7870 g · 100 g | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.